Live feed
Filing
SC 13G
SC 13G0001654954-22-001710·Mosseri Marlio Charles
Schedule 13G ownership disclosure
Nuvectis Pharma, Inc.
Security class unavailable
Event date: 2022-02-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001654954-22-001710
- Form type
- SC 13G
- Filer
- Mosseri Marlio Charles
- CIK
- CIK 1806384
- Filed
- Feb 15, 2022
- Reporting period
- Feb 08, 2022
- Description
- Schedule 13G beneficial ownership